Startup | May 20, 2024
IIHMR Start-ups inks MoU with BMCHRC & HCG Hospital
The collaboration aims to bolster healthcare entrepreneurship
The collaboration aims to bolster healthcare entrepreneurship
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
EBITDA before special items falls 1.3 percent to € 4.41 billion
These devices instantly detect various arrhythmias, including atrial fibrillation (Afib), bradycardia, tachycardia, and more
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Sales reflect continued strong growth in oncology and vaccines
Subscribe To Our Newsletter & Stay Updated
